Splice variants of protein disulfide isomerase - identification, distribution and functional characterization in the rat

Archive ouverte

Chetot, Thomas | Serfaty, Xavier | Carret, Léna | Kriznik, Alexandre | Rahuel-Clermont, Sophie | Grand, Lucie | Jacolot, Maïwenn | Popowycz, Florence | Benoit, Etienne | Lambert, Véronique | Lattard, Virginie

Edité par CCSD ; Elsevier -

3/2. International audience. Background: Protein Disulfide Isomerase (PDI) enzyme is an emerging therapeutic target in oncology and hematology. Although PDI reductase activity has been studied with isolated fragments of the protein, natural structural variations affecting reductase activity have not been addressed.Methods: In this study, we discovered four coding splice variants of the Pdi pre-mRNA in rats. In vitro Michaelis constants and apparent maximum steady-state rate constants after purification and distribution in different rat tissues were determined.Results: The consensus sequence was found to be the most expressed splice variant while the second most expressed variant represents 15 to 35% of total Pdi mRNA. The third variant shows a quasi-null expression profile and the fourth was not quantifiable. The consensus sequence splice variant and the second splice variant are widely expressed (transcription level) in the liver and even more present in males. Measurements of the reductase activity of recombinant PDI indicate that the consensus sequence and third splice variant are fully active variants. The second most expressed variant, differing by a lack of signal peptide, was found active but less than the consensus sequence.General significance: Our work emphasizes the importance of taking splice variants into account when studying PDI-like proteins to understand the full biological functionalities of PDI.

Suggestions

Du même auteur

Design of a structure-activity relationship model of vitamin K epoxide reductase (VKORC1) inhibitors combining chemical synthesis of new compounds, enzymatic assays and molecular modelling

Archive ouverte | Chatron, Nolan | CCSD

2. International audience. Vitamin K antagonists (VKAs) anticoagulants have been used since the 1950s as medicines and rodenticides. These molecules are mainly 4-hydroxycoumarin derivatives and act by inhibiting the...

Overexpression of protein disulfide isomerase enhances vitamin K epoxide reductase activity

Archive ouverte | Chetot, Thomas | CCSD

International audience. Vitamin K epoxide reductase (VKOR) activity is catalyzed by the VKORC1 enzyme. It is a target of vitamin K antagonists (VKA). Numerous mutations of VKORC1 have been reported and are suspected...

Vitamin K antagonist rodenticides display different teratogenic activity

Archive ouverte | Chetot, Thomas | CCSD

International audience. Vitamin K antagonists (VKA) are not recommended during pregnancy because warfarin (a first-generation VKA) is associated with a malformation syndrome "the fetal warfarin syndrome" (FWS). VKA ...

Chargement des enrichissements...